Aromatase Inhibitor [EPC]

65873 reported adverse events

Drugs of this class: ANASTROZOLE LETROZOLE EXEMESTANE ANASTROZOLE TABLETS LETROZOLE TABLETS TESTOSTERONE / ANASTROZOLE

These side effects are most commonly reported by patients taking drugs of the Aromatase Inhibitor [EPC] class:

# Side effect Count
0 FATIGUE 6224
1 NAUSEA 4634
2 ARTHRALGIA 4599
3 ALOPECIA 4490
4 DIARRHOEA 3698
5 MALIGNANT NEOPLASM PROGRESSION 3242
6 PAIN 3171
7 DYSPNOEA 2956
8 ASTHENIA 2578
9 NEUTROPENIA 2536
See all common reactions for Aromatase Inhibitor [EPC]

Drugs of the Aromatase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PIK3CA-ACTIVATED MUTATION 58 0.6591
1 CARBOHYDRATE ANTIGEN 15-3 INCREASED 164 0.5000
2 CARBOHYDRATE ANTIGEN 27.29 INCREASED 40 0.4545
3 PSEUDOCIRRHOSIS 66 0.3587
4 METASTASES TO CHEST WALL 61 0.2990
5 BREAST CANCER RECURRENT 541 0.2712
6 METASTASES TO THE MEDIASTINUM 67 0.2463
7 METASTASES TO SKIN 140 0.2265
8 METASTASES TO PLEURA 127 0.2252
9 METASTASES TO OVARY 42 0.2188
See all enriched reactions for Aromatase Inhibitor [EPC]